2:I[6146,[],""]
3:I[4411,[],""]
4:"$Sreact.suspense"
5:I[7256,["863","static/chunks/863-822c2cde35e02348.js","185","static/chunks/app/layout-fb78cfc571d4c3d6.js"],"KeyboardNavigation"]
6:I[5407,["863","static/chunks/863-822c2cde35e02348.js","185","static/chunks/app/layout-fb78cfc571d4c3d6.js"],"SlideNavigation"]
0:["DkpgZd6XOJjDaY981EGFp",[[["",{"children":["pages",{"children":["2",{"children":["__PAGE__",{}]}]}]},"$undefined","$undefined",true],["",{"children":["pages",{"children":["2",{"children":["__PAGE__",{},[["$L1",["$","div",null,{"className":"relative overflow-hidden w-[1920px] h-[1080px] bg-gradient-to-br from-slate-900 to-slate-700 text-white","children":["$","div",null,{"className":"flex flex-col w-full h-full","children":[["$","div",null,{"className":"flex-none bg-slate-800/90 p-6 flex items-center gap-4","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":48,"height":48,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-file-text text-blue-400","children":[["$","path","1rqfz7",{"d":"M15 2H6a2 2 0 0 0-2 2v16a2 2 0 0 0 2 2h12a2 2 0 0 0 2-2V7Z"}],["$","path","tnqrlb",{"d":"M14 2v4a2 2 0 0 0 2 2h4"}],["$","path","b1mrlr",{"d":"M10 9H8"}],["$","path","t4e002",{"d":"M16 13H8"}],["$","path","z1uh3a",{"d":"M16 17H8"}],"$undefined"]}],["$","h1",null,{"className":"text-6xl font-bold text-white","children":"Executive Summary"}]]}],["$","div",null,{"className":"flex-1 min-h-0 grid grid-cols-[1fr_1fr] grid-rows-[auto_1fr] gap-8 p-8","children":[["$","div",null,{"className":"col-span-2 bg-slate-800 p-6 border-l-4 border-blue-400 rounded-lg","children":["$","p",null,{"className":"text-3xl leading-relaxed","children":"Unloxcyt (cosibelimab-ipdl) is the first and only FDA-approved PD-L1 inhibitor for metastatic or locally advanced cutaneous squamous cell carcinoma, entering a U.S. market exceeding $1 billion annually with peak sales potential of $1.0-1.6 billion."}]}],["$","div",null,{"className":"flex flex-col gap-6","children":[["$","div",null,{"className":"bg-slate-800/80 p-4 rounded-lg flex items-center gap-4","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":36,"height":36,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-circle-check-big text-green-400","children":[["$","path","yps3ct",{"d":"M21.801 10A10 10 0 1 1 17 3.335"}],["$","path","1pflzl",{"d":"m9 11 3 3L22 4"}],"$undefined"]}],["$","div",null,{"children":[["$","p",null,{"className":"text-xl text-gray-300","children":"FDA Approval Date"}],["$","p",null,{"className":"text-4xl font-bold text-white","children":"December 13, 2024"}]]}]]}],["$","div",null,{"className":"bg-slate-800/80 p-4 rounded-lg flex items-center gap-4","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":36,"height":36,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-dollar-sign text-blue-400","children":[["$","line","7eqyqh",{"x1":"12","x2":"12","y1":"2","y2":"22"}],["$","path","1b0p4s",{"d":"M17 5H9.5a3.5 3.5 0 0 0 0 7h5a3.5 3.5 0 0 1 0 7H6"}],"$undefined"]}],["$","div",null,{"children":[["$","p",null,{"className":"text-xl text-gray-300","children":"Acquisition Value"}],["$","p",null,{"className":"text-4xl font-bold text-white","children":"$$416M"}]]}]]}],["$","div",null,{"className":"bg-slate-800/80 p-4 rounded-lg flex items-center gap-4","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":36,"height":36,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-trending-up text-green-400","children":[["$","polyline","126l90",{"points":"22 7 13.5 15.5 8.5 10.5 2 17"}],["$","polyline","kwv8wd",{"points":"16 7 22 7 22 13"}],"$undefined"]}],["$","div",null,{"children":[["$","p",null,{"className":"text-xl text-gray-300","children":"U.S. Market Size"}],["$","p",null,{"className":"text-4xl font-bold text-white","children":"$$1B+"}]]}]]}],["$","div",null,{"className":"bg-slate-800/80 p-4 rounded-lg flex items-center gap-4","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":36,"height":36,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-target text-purple-400","children":[["$","circle","1mglay",{"cx":"12","cy":"12","r":"10"}],["$","circle","1vlfrh",{"cx":"12","cy":"12","r":"6"}],["$","circle","1c9p78",{"cx":"12","cy":"12","r":"2"}],"$undefined"]}],["$","div",null,{"children":[["$","p",null,{"className":"text-xl text-gray-300","children":"Peak Sales Potential"}],["$","p",null,{"className":"text-4xl font-bold text-white","children":"$$1.0-1.6B"}]]}]]}],["$","div",null,{"className":"bg-slate-800/80 p-4 rounded-lg flex items-center gap-4","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":36,"height":36,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-activity text-green-400","children":[["$","path","169zse",{"d":"M22 12h-2.48a2 2 0 0 0-1.93 1.46l-2.35 8.36a.25.25 0 0 1-.48 0L9.24 2.18a.25.25 0 0 0-.48 0l-2.35 8.36A2 2 0 0 1 4.49 12H2"}],"$undefined"]}],["$","div",null,{"children":[["$","p",null,{"className":"text-xl text-gray-300","children":"Objective Response Rate"}],["$","p",null,{"className":"text-4xl font-bold text-white","children":"47-48%"}]]}]]}]]}],["$","div",null,{"className":"bg-slate-800/80 p-6 rounded-lg","children":[["$","h3",null,{"className":"text-4xl font-bold text-purple-400 mb-6","children":"Key Strategic Highlights"}],["$","div",null,{"className":"space-y-4","children":[["$","div",null,{"className":"flex items-start gap-3","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":20,"height":20,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-circle-check-big text-blue-400 mt-1","children":[["$","path","yps3ct",{"d":"M21.801 10A10 10 0 1 1 17 3.335"}],["$","path","1pflzl",{"d":"m9 11 3 3L22 4"}],"$undefined"]}],["$","p",null,{"className":"text-2xl","children":"First-in-class PD-L1 mechanism with ADCC activity providing differentiation from PD-1 inhibitors"}]]}],["$","div",null,{"className":"flex items-start gap-3","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":20,"height":20,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-circle-check-big text-blue-400 mt-1","children":[["$","path","yps3ct",{"d":"M21.801 10A10 10 0 1 1 17 3.335"}],["$","path","1pflzl",{"d":"m9 11 3 3L22 4"}],"$undefined"]}],["$","p",null,{"className":"text-2xl","children":"Strong clinical efficacy with durable responses in Phase 1 trial (47% ORR, not reached median duration)"}]]}],["$","div",null,{"className":"flex items-start gap-3","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":20,"height":20,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-circle-check-big text-blue-400 mt-1","children":[["$","path","yps3ct",{"d":"M21.801 10A10 10 0 1 1 17 3.335"}],["$","path","1pflzl",{"d":"m9 11 3 3L22 4"}],"$undefined"]}],["$","p",null,{"className":"text-2xl","children":"Sun Pharma acquisition provides global commercialization infrastructure and dermatology expertise"}]]}],["$","div",null,{"className":"flex items-start gap-3","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":20,"height":20,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-circle-check-big text-blue-400 mt-1","children":[["$","path","yps3ct",{"d":"M21.801 10A10 10 0 1 1 17 3.335"}],["$","path","1pflzl",{"d":"m9 11 3 3L22 4"}],"$undefined"]}],["$","p",null,{"className":"text-2xl","children":"Competitive landscape dominated by Keytruda and Libtayo presents both challenges and opportunities"}]]}],["$","div",null,{"className":"flex items-start gap-3","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":20,"height":20,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-circle-check-big text-blue-400 mt-1","children":[["$","path","yps3ct",{"d":"M21.801 10A10 10 0 1 1 17 3.335"}],["$","path","1pflzl",{"d":"m9 11 3 3L22 4"}],"$undefined"]}],["$","p",null,{"className":"text-2xl","children":"European expansion planned with EMA/UK MHRA submissions adding $250-400M peak sales potential"}]]}]]}]]}]]}],["$","div",null,{"className":"flex-none p-4 text-right","children":["$","p",null,{"className":"text-xl text-gray-400","children":"2"}]}]]}]}],null],null],null]},[null,["$","$L2",null,{"parallelRouterKey":"children","segmentPath":["children","pages","children","2","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L3",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined"}]],null]},[null,["$","$L2",null,{"parallelRouterKey":"children","segmentPath":["children","pages","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L3",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined"}]],null]},[[[["$","link","0",{"rel":"stylesheet","href":"/_next/static/css/8d323862949ffad9.css","precedence":"next","crossOrigin":"$undefined"}]],["$","html",null,{"lang":"en","className":"dark","children":["$","body",null,{"className":"__className_f367f3 h-1080px w-1920px","children":[["$","$4",null,{"fallback":null,"children":[["$","$L5",null,{}],["$","$L6",null,{}]]}],["$","$L2",null,{"parallelRouterKey":"children","segmentPath":["children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L3",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":[["$","title",null,{"children":"404: This page could not be found."}],["$","div",null,{"style":{"fontFamily":"system-ui,\"Segoe UI\",Roboto,Helvetica,Arial,sans-serif,\"Apple Color Emoji\",\"Segoe UI Emoji\"","height":"100vh","textAlign":"center","display":"flex","flexDirection":"column","alignItems":"center","justifyContent":"center"},"children":["$","div",null,{"children":[["$","style",null,{"dangerouslySetInnerHTML":{"__html":"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}"}}],["$","h1",null,{"className":"next-error-h1","style":{"display":"inline-block","margin":"0 20px 0 0","padding":"0 23px 0 0","fontSize":24,"fontWeight":500,"verticalAlign":"top","lineHeight":"49px"},"children":"404"}],["$","div",null,{"style":{"display":"inline-block"},"children":["$","h2",null,{"style":{"fontSize":14,"fontWeight":400,"lineHeight":"49px","margin":0},"children":"This page could not be found."}]}]]}]}]],"notFoundStyles":[]}]]}]}]],null],null],["$L7",null]]]]
7:[["$","meta","0",{"name":"viewport","content":"width=device-width, initial-scale=1"}],["$","meta","1",{"charSet":"utf-8"}],["$","title","2",{"children":"Unloxcyt Market Survey - Interactive Presentation"}],["$","meta","3",{"name":"description","content":"Comprehensive market analysis of Cosibelimab-ipdl for advanced cSCC"}],["$","meta","4",{"name":"next-size-adjust"}]]
1:null
